How Pharma Can Use Behavioral Science to Balance Global Efficiency with Local Relevance

Global consistency or local relevance? For pharma organizations developing digital health and patient support programs, achieving both has become one of the industry's biggest strategic challenges.

While global strategies provide consistency, strategic alignment, and compliance, their real-world success depends on how well they adapt to the structural, cultural, and behavioral realities of local healthcare systems.

Yet many organizations still approach these as competing priorities, resulting in either rigid global programs that fail to fit local healthcare systems or fragmented local initiatives that duplicate effort and increase cost.

This whitepaper argues that the answer is neither complete standardization nor unrestricted localization. Instead, it introduces a practical approach based on disciplined adaptation using behavioral science to determine what should remain globally consistent and where local variation genuinely creates value.

Drawing on insights from experts at Astellas Pharma, Merz Therapeutics, Novartis, and S3 Connected Health, the paper demonstrates why most behavioral barriers are universal, why most implementation realities are local, and how organizations can build scalable global programs without sacrificing relevance in individual markets.

The whitepaper provides a structured framework for identifying the specific behavioral and environmental variables that justify adaptation, enabling more consistent, evidence-based decision making across global organizations. 

In this whitepaper, you will learn: 

• How to balance global consistency with local relevance by identifying what should remain standardized and where targeted adaptation creates genuine value. 
• How behavioral science provides a practical framework for decision-making, helping teams distinguish universal behavioral barriers from local implementation realities. 
• A three-step approach for designing globally scalable, locally relevant digital health programs, supported by practical examples and real-world industry insights. 
• How to improve the success of global programs by focusing not only on localization decisions, but also on execution, measurement, and long-term adoption
  
  
  

File Size: 2.5 MB